The VEGF Inhibitor Axitinib Has Limited Effectiveness as a Therapy for Adrenocortical Cancer

CONTEXT: Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis in need of more effective treatment options. Published evidence indicates many ACCs express the vascular endothelial growth factor receptor (VEGFR), suggesting inhibiting vascular endothelial growth factor signaling c...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: O'Sullivan, Ciara, Edgerly, Maureen, Velarde, Margarita, Wilkerson, Julia, Venkatesan, Aradhana M., Pittaluga, Stefania, Yang, Sherry X., Nguyen, Dat, Balasubramaniam, Sanjeeve, Fojo, Tito
Médium: Artigo
Jazyk:Inglês
Vydáno: Endocrine Society 2014
Témata:
Endocrine Care
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3973787/
https://ncbi.nlm.nih.gov/pubmed/24423320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2013-2298
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky